Ads
related to: new congestive heart failure drugs- Things You Should Know
View Important Safety Information.
Heart Failure Facts & Information.
- Hospital Results
Outcomes In The Hospital Setting.
Learn About Management Guideline.
- Patient Coverage
Pay As Little As $10.
Search For Patient Coverage.
- Clinical Data
Clinical Trial Data For HCPs.
Learn More About Heart Failure.
- Page Of Helpful Links
Review The Doctor Discussion Guide.
Heart Failure Education.
- Clinical Trail Safety
Proven Safety Profile In Patients.
Review Clinical Research & Data.
- Things You Should Know
Search results
Results From The WOW.Com Content Network
A new paper was published on these findings and MedCo filed for a new patent for the drug as a treatment for heart failure specifically in black patients. [ 4 ] [ 7 ] [ 8 ] The new patent and the old patent were then licensed to a company called NitroMed, which ran a clinical called the African-American Heart Failure Trial (A-HeFT), the results ...
Amrinone, also known as inamrinone, and sold as Inocor, is a pyridine phosphodiesterase 3 inhibitor. [1] It is a drug that may improve the prognosis in patients with congestive heart failure. [2]
Drug examples General indications Common side effects Cautions Special populations Digoxin [8]. Digitalis [8]. Digitoxin [8]. Heart failure with reduced ejection fraction [9]. Atrial Fibrillation (abnormal heart rhythm) [9]
"Using stem cells from patients with heart failure caused by chemo, we are actively developing new drugs and cell-based treatments that we believe will transform the lives of patients with these ...
People with heart failure, also known as congestive heart failure (CHF), are educated to undertake various non-pharmacological measures to improve symptoms and prognosis. Such measures include: [2] Moderate physical activity, when symptoms are mild or moderate; or bed rest when symptoms are severe. In individuals with heart failure, increasing ...
Similarly, the ACC/AHA recommends against using COX-2 inhibitor medications in people with heart failure. [54] Thiazolidinediones have been strongly linked to new cases of heart failure and worsening of pre-existing congestive heart failure due to their association with weight gain and fluid retention. [54]
Ads
related to: new congestive heart failure drugs